Genetic Marker May Guide Brain Cancer Treatment | Mirage News
University of Kentucky University of Kentucky Markey Cancer Center researchers have discovered a genetic biomarker that could help identify patients with glioblastoma most likely to benefit from the cancer drug bevacizumab. The study, published in JCO Precision Oncology, found that brain tumors from patients treated with bevacizumab who lived longer…
bubmagJuly 25, 2025